Myda Advisors LLC Tg Therapeutics, Inc. Transaction History
Myda Advisors LLC
- $364 Million
- Q4 2024
A detailed history of Myda Advisors LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Myda Advisors LLC holds 55,000 shares of TGTX stock, worth $1.69 Million. This represents 0.45% of its overall portfolio holdings.
Number of Shares
55,000
Previous 40,000
37.5%
Holding current value
$1.69 Million
Previous $935,000
77.01%
% of portfolio
0.45%
Previous 0.23%
Shares
3 transactions
Others Institutions Holding TGTX
# of Institutions
371Shares Held
85.9MCall Options Held
3.64MPut Options Held
2.59M-
Vanguard Group Inc Valley Forge, PA15.6MShares$479 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$350 Million0.0% of portfolio
-
State Street Corp Boston, MA9.2MShares$283 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.19MShares$98.1 Million0.01% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V82.79MShares$85.9 Million0.09% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.46B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...